May 12, 2022 / 09:00PM GMT
Operator
Thank you for standing by, and welcome to the KemPharm First Quarter 2022 Results Conference Call. (Operator Instructions) Please be advised that today's call may be recorded. (Operator Instructions)
I would now like to hand the call over to your host, Jason Rando with Tiberend Strategic Advisors. Please go ahead.
Jason Rando - Tiberend Strategic Advisors, Inc. - COO & EVP
Good afternoon, and thank you for joining our call today to discuss KemPharm's First Quarter 2021 Financial and Corporate Results.
Before we begin, I would like to remind our listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties and are subject to change at any time, including but not limited to, statements about KemPharm's expectations regarding future operating results. Forward-looking statements are made pursuant to the safe harbor provisions of the federal securities laws and represent management's current expectations. Actual results may differ materially.
KemPharm disclaims any obligation
Q1 2022 KemPharm Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
